ProKidney Corp. targets diabetic CKD with Rilparencel and expects Q2 2027 eGFR slope data for accelerated approval. Find out ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...

The discovery addresses resistance amongst patients after one to two years of treatment. Researchers at Agency for Science, ...

Spanish scientist Dr Mariano Barbacid and his team have developed a targeted therapy that eliminated pancreatic tumours in mice, marking a significant breakthrough.

Epithelial–mesenchymal transition (EMT) is a biological process that involves the transformation of epithelial cells into ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by targeting the KRAS pathway, raising hopes for future human trials.

Proteomics experiments on Drosophila reveal sex-specific effects in aging, and an important role for a protein called DIP-β.

Led by renowned cancer biologist Mariano Barbacid, the researchers have managed to make pancreatic tumours completely and ...

A Spanish study wipes out pancreatic cancer in mice, causing viral claims of a cure. Breakthrough science or false hope?